Evidence map›Paper›PMID 22710646›Full record

ArticleHypertension (Dallas, Tex. : 1979)2012

Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells.

John J Gildea, Xiaoli Wang, Neema Shah, Hanh Tran, Michael Spinosa, Robert Van Sciver, Midori Sasaki, Junichi Yatabe, Robert M Carey, Pedro A Jose and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. The Renin-Angiotensin and Renal Dopaminergic Systems Interact in Normotensive Humans.Journal of the American Society of Nephrology : JASN · 2016
    Trial
  3. Article
  4. Review
  5. The Angiotensin ATPharmacological reviews · 2022
    Review
  6. Review
  7. Review
  8. Renal ATCirculation research · 2022
    Article
  9. Identification of a Primary Renal ATCirculation research · 2020
    Article
  10. The Dopamine DHypertension (Dallas, Tex. : 1979) · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

John J GildeaUniversity of Virginia, Charlottesville, VA 22908, USA. jjg5b@virginia.edu
Xiaoli Wang
Neema Shah
Hanh Tran
Michael Spinosa
Robert Van Sciver
Midori Sasaki
Junichi Yatabe
Robert M Carey
Pedro A Jose
Robin A Felder
Shenzhen Polytechnic · CNFukushima Medical University · JP

Funding

Spatiotemporal transregulation of D1-like angiotensin receptors in genetically...P01HL074940 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI JOSE, PEDRO A. · 2004 to 2020
$31.8M
RENAL DOPAMINE-1 RECEPTOR DEFECT IN HYPERTENSIONR01DK039308 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI JOSE, PEDRO A. · 1987 to 2020
$7.4M
Renal AT2 Receptors in HypertensionR01HL095796 · NHLBI · UNIVERSITY OF VIRGINIA · PI CAREY, ROBERT MUNSON · 2010 to 2013
$1.7M
NHLBI NIH HHS P01 HL074940NHLBI NIH HHS P01HL074940NHLBI NIH HHS R01 HL095796NHLBI NIH HHS R01HL095796NIDDK NIH HHS R01 DK039308NIDDK NIH HHS R01DK039308
6 · The paper itself

Abstract

Little is known regarding how the kidney shifts from a sodium and water reclaiming state (antinatriuresis) to a state where sodium and water are eliminated (natriuresis). In human renal proximal tubule cells, sodium reabsorption is decreased by the dopamine D(1)-like receptors (D(1)R/D(5)R) and the angiotensin type 2 receptor (AT(2)R), whereas the angiotensin type 1 receptor increases sodium reabsorption. Aberrant control of these opposing systems is thought to lead to sodium retention and, subsequently, hypertension. We show that D(1)R/D(5)R stimulation increased plasma membrane AT(2)R 4-fold via a D(1)R-mediated, cAMP-coupled, and protein phosphatase 2A-dependent specific signaling pathway. D(1)R/D(5)R stimulation also reduced the ability of angiotensin II to stimulate phospho-extracellular signal-regulated kinase, an effect that was partially reversed by an AT(2)R antagonist. Fenoldopam did not increase AT(2)R recruitment in renal proximal tubule cells with D(1)Rs uncoupled from adenylyl cyclase, suggesting a role of cAMP in mediating these events. D(1)Rs and AT(2)Rs heterodimerized and cooperatively increased cAMP and cGMP production, protein phosphatase 2A activation, sodium-potassium-ATPase internalization, and sodium transport inhibition. These studies shed new light on the regulation of renal sodium transport by the dopaminergic and angiotensin systems and potential new therapeutic targets for selectively treating hypertension.

Indexed as

Biological TransportCell LineCells, CulturedCyclic AMPCyclic GMPHumansKidney Tubules, ProximalProtein Phosphatase 2Receptor, Angiotensin, Type 2Receptors, DopamineSignal TransductionSodiumSodium-Potassium-Exchanging ATPaseCyclic AMPCyclic GMPProtein Phosphatase 2Receptor, Angiotensin, Type 2Receptors, DopamineSodiumSodium-Potassium-Exchanging ATPase

Identifiers

PMID22710646
PMCPMC3406928
OpenAlexW2146433687

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.